The achievements of Scott Rocklage have inspired people who are interested in being entrepreneurs or biochemical researcher. Scott Rocklage having achieved a bachelor of science degree in chemistry in the University of California and a PhD degree in chemistry at Massachusetts Institute of Technology, he was able to attain a position as controlling partner in 5AM Ventures. Scott Rocklage began working in this company in the year 2003.

Scott Rocklage has a vast experience which has been for more than 20 years in the department of health management. His vast experience in science has been able to strengthen his background. This experience and leadership skills have helped him to become a well-recognized leader in venture capital, healthcare and pharmaceuticals. Read more: Scott Racklage | Bloomberg and Scott Rocklage | LinkedIn

Scott Rocklage apart from the being a managing partner for 5AM, he is also the chairman of various boards such as: Semprus, Relypsa, Achaogen, Pulmatrix, WaveRx, Variation, Kinestral, Rennovia, Epirus and Cidara Therapeutics.

He also in the management board of Whitehead Institute. Scott Rocklage has been the president or chairman of Nycomed Salutar, the head of the board of J&J-acquired Novira. Scott Rocklage has also been the Executive chairman of Miikana and Ilypsa. His extensive experience in leadership.

Scott Rocklage did his doctorate research at the laboratory of one of the Nobel Prize winners Richard R.Schrock . Due to the vast experience and leadership skills of Scott Rocklage, he has led to the approval by the FDA of three drug applications in United States.

The success of the leadership skills of Scott Rocklage has been accredited by Cubicin, Teslascan and Omniscan. Scott has managed to bring in six drug candidates into clinical tests. He also has publications under his name that are more than 100.

The company that Scott Rocklage currently manages 5AM Ventures is a venture capital firm whose focus is on life science. Scott Rocklage became a venture partner in 2003 and he later became the managing partner in 2004.

His duties are to conduct and attend board meetings, to come into terms with the company’s portfolio management team and to go through the new life sciences. Scott has worked with professional in the healthcare to innovate medical solutions to some of the unresolved medical cases today.